Acrospire Investment Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10
Closed 1049
2017
Q2
$0 Sell
10
-290
-97% -$6.36K ﹤0.01% 2453
2017
Q1
$6K Sell
300
-2,223
-88% -$49.6K 0.01% 1975
2016
Q4
$61K Sell
2,523
-706
-22% -$19.7K 0.03% 1273
2016
Q3
$90K Buy
3,229
+706
+28% +$18.7K 0.06% 639
2016
Q2
$62K Buy
2,523
+1,211
+92% +$34.4K 0.05% 884
2016
Q1
$44K Buy
+1,312
New +$41.3K 0.03% 1062

Other funds holding PGEN

Acrospire Investment Management's PGEN Position: Q3 2017 in Review

Acrospire Investment Management sold out of Precigen (PGEN) in Q3 2017, closing a stake of 10 shares.

Acrospire Investment Management first reported a position in PGEN in Q1 2016 and held it in 6 quarters. The position peaked at $90K in Q3 2016. 155 funds tracked by Wall St. Rank hold PGEN as of Q3 2017.

  • Acrospire Investment Management reported no remaining Precigen position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 10 Precigen shares in Q3 2017.
  • Acrospire Investment Management first reported a position in Precigen in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Precigen position peaked at $90K in Q3 2016.
  • 155 funds tracked by Wall St. Rank held Precigen as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.